|
|
|
|
| LEADER |
00000cam a2200000Ka 4500 |
| 001 |
in00003504904 |
| 005 |
20190407121907.0 |
| 006 |
m o d |
| 007 |
cr un||||a|a|| |
| 008 |
100723s2001 njua ob 001 0 eng d |
| 019 |
|
|
|a 170760606
|a 606416379
|a 648272562
|
| 020 |
|
|
|a 9781592590063 (electronic bk.)
|
| 020 |
|
|
|a 1592590063 (electronic bk.)
|
| 020 |
|
|
|z 0896038041 (alk. paper)
|
| 020 |
|
|
|z 9780896038042 (alk. paper)
|
| 035 |
|
|
|a (OCoLC)ocn650035507
|
| 035 |
|
|
|a (OCoLC)650035507
|z (OCoLC)170760606
|z (OCoLC)606416379
|z (OCoLC)648272562
|
| 040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d N$T
|d YDXCP
|d OCLCQ
|d IDEBK
|d E7B
|d OCLCQ
|d NUI
|d OCLCO
|d OCLCQ
|d OCLCF
|d GW5XE
|d UtOrBLW
|
| 042 |
|
|
|a dlr
|
| 049 |
|
|
|a TXAM
|
| 050 |
|
4 |
|a RC365
|b .M64 2001
|
| 060 |
|
4 |
|a 2000 N-730
|
| 060 |
|
4 |
|a WL 359
|b M718 2001
|
| 072 |
|
7 |
|a HEA
|x 039110
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 056000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.8/047
|2 21
|
| 084 |
|
|
|a 44.90
|2 bcl
|
| 084 |
|
|
|a XG 8600
|2 rvk
|
| 245 |
0 |
0 |
|a Molecular mechanisms of neurodegenerative diseases /
|c [edited by] Marie-Francoise Chesselet.
|
| 264 |
|
1 |
|a Totowa, N.J. :
|b Humana,
|c 2001.
|
| 300 |
|
|
|a 1 online resource (xiii, 410 pages) :
|b illustrations (some color).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Contemporary clinical neuroscience
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 520 |
|
|
|a With the unprecedented identification of new mutation mechanisms in neurodegenerative diseases and the emergence of common mechanisms among diseases that were once considered unrelated, neurobiologists are poised for the development of new therapies based on high throughput screenings and a better understanding of the molecular and cellular mechanisms leading to neurodegeneration. In Molecular Mechanisms of Neurodegenerative Diseases, Marie-Francoise Chesselet, MD, PhD, and a panel of leading researchers and neurologists from industry and academia critically review the most recent advances from different yet complementary points of view. Focusing on Alzheimer's, Parkinson's, and CAG triplet repeat diseases, the authors show how studies of cellular and genetically engineered animal models have enhanced our understanding of the molecular mechanisms of neurodegenerative diseases and may lead to the development of new therapeutics. Topics include the role of Ab toxicity, glial cells, and inflammation in Alzheimer's disease; the formation of abnormal protein fragments across several diseases, the impact of dopamine and mitochondrial dysfunction on neurodegeneration; and the potential of genetics to identify the molecular mechanisms of neurodegenerative diseases. Authoritative and insightful, Molecular Mechanisms of Neurodegenerative Diseases synthesizes the novel ideas and concepts now emerging to create a fresh understanding of neurodegenerative disorders, one that promises to lead to powerful new therapies that prevent, delay the onset, slow the progression, or even cure these cruel diseases.
|
| 538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
| 583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
| 588 |
|
|
|a Description based on print version record.
|
| 500 |
|
|
|a Electronic resource.
|
| 650 |
|
0 |
|a Nervous system
|x Degeneration
|x Molecular aspects.
|
| 650 |
|
0 |
|a Molecular neurobiology.
|
| 650 |
1 |
2 |
|a Neurodegenerative Diseases
|x genetics.
|
| 650 |
2 |
2 |
|a Neurodegenerative Diseases
|x physiopathology.
|
| 650 |
|
6 |
|a Système nerveux
|x Dégénérescence
|x Aspect moléculaire.
|
| 650 |
|
6 |
|a Neurobiologie moléculaire.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Nervous System (incl. Brain)
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Neurology.
|2 bisacsh
|
| 650 |
1 |
7 |
|a Zenuwstelselaandoeningen.
|2 gtt
|
| 650 |
1 |
7 |
|a Moleculaire biologie.
|2 gtt
|
| 650 |
1 |
7 |
|a Neurologie.
|2 gtt
|
| 650 |
1 |
7 |
|a Degeneratie.
|2 gtt
|
| 650 |
1 |
7 |
|a Neurobiologie.
|2 gtt
|
| 650 |
|
7 |
|a Système nerveux
|x Dégénérescence
|x Aspect moléculaire.
|2 ram
|
| 650 |
|
7 |
|a Neurobiologie moléculaire.
|2 ram
|
| 650 |
0 |
7 |
|a Pathophysiologie.
|2 swd
|
| 650 |
0 |
7 |
|a Nervendegeneration.
|2 swd
|
| 650 |
0 |
7 |
|a Molekularpathologie.
|2 swd
|
| 650 |
|
7 |
|a Molecular neurobiology.
|2 fast
|0 (OCoLC)fst01024815
|
| 650 |
|
7 |
|a Nervous system
|x Degeneration
|x Molecular aspects.
|2 fast
|0 (OCoLC)fst01036094
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Chesselet, Marie-Françoise.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 776 |
1 |
8 |
|i Print version:
|t Molecular mechanisms of neurodegenerative diseases.
|d Totowa, N.J. : Humana, 2001
|w (DLC) 00032041
|w (OCoLC)43905984
|
| 830 |
|
0 |
|a Contemporary clinical neuroscience.
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=http://link.springer.com/10.1007/978-1-59259-006-3
|z Connect to the full text of this electronic book
|t 0
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 4586e288-6039-34c9-a993-6f3b07384506
|i ae6a4d78-520a-3c27-b981-75b7ccabcc8a
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e RC365 .M64 2001
|h Library of Congress classification
|
| 998 |
f |
f |
|a RC365 .M64 2001
|t 0
|l Available Online
|